Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Biohaven Ltd. chart...

About the Company

We do not have any company description for Biohaven Ltd. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

77

Exchange

NYSE

$738M

Total Revenue

77

Employees

$3B

Market Capitalization

-6.82

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $BHVN News

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

2d ago, source:

Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, ...

Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)

1d ago, source:

Director Gregory Bailey has recently increased his stake in Biohaven Ltd (NYSE:BHVN) by purchasing 48,780 shares of the ...

Biohaven Prices Offering Of $230 Mln Of Shares At $41/share; Stock Down In Pre-Market

6d ago, source:

Biohaven Ltd. (BHVN) on Thursday announced the pricing of its underwritten public offering of 5,609,757 shares at $41 per share for ...

Biohaven Stock (NYSE:BHVN), Analyst Ratings, Price Targets, Predictions

2d ago, source: Benzinga.com

There is no last upgrade for Biohaven.

Buy Rating Affirmed for Biohaven Ltd. Amid Positive Clinical Outlook and Pipeline Potential

10d ago, source:

J.P. Morgan analyst Tessa Romero has maintained their bullish stance on BHVN stock, giving a Buy rating yesterday. Tessa Romero has given his ...

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares

7d ago, source: The Victoria Advocate

NEW HAVEN, Conn., April 18, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments ...

Biohaven Announces Proposed Public Offering of Common Shares

8d ago, source: Stockhouse

NEW HAVEN, Conn., April 17, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key ...

Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock

1mon ago, source:

In the last year, multiple insiders have substantially increased their holdings of Biohaven Ltd. ( NYSE:BHVN ) ...

Biohaven Ltd BHVN

10d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Biohaven Ltd.: Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments

1mon ago, source: Finanznachrichten

NEW HAVEN, Conn., Feb. 29, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...